These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Inhalable microparticles containing nitric oxide donors: saying NO to intracellular Mycobacterium tuberculosis. Verma RK; Singh AK; Mohan M; Agrawal AK; Verma PR; Gupta A; Misra A Mol Pharm; 2012 Nov; 9(11):3183-9. PubMed ID: 22978290 [TBL] [Abstract][Full Text] [Related]
11. Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment. Cunha L; Rodrigues S; Rosa da Costa AM; Faleiro L; Buttini F; Grenha A Drug Dev Ind Pharm; 2019 Aug; 45(8):1313-1320. PubMed ID: 30990096 [TBL] [Abstract][Full Text] [Related]
12. Inhalable Particles for "Pincer Therapeutics" Targeting Nitazoxanide as Bactericidal and Host-Directed Agent to Macrophages in a Mouse Model of Tuberculosis. Gupta A; Meena J; Sharma D; Gupta P; Gupta UD; Kumar S; Sharma S; Panda AK; Misra A Mol Pharm; 2016 Sep; 13(9):3247-55. PubMed ID: 27463245 [TBL] [Abstract][Full Text] [Related]
13. Spray-dried fucoidan microparticles for pulmonary delivery of antitubercular drugs. Cunha L; Rosa da Costa AM; Lourenço JP; Buttini F; Grenha A J Microencapsul; 2018 Jun; 35(4):392-405. PubMed ID: 30112917 [TBL] [Abstract][Full Text] [Related]
14. Dual antibiotherapy of tuberculosis mediated by inhalable locust bean gum microparticles. Rodrigues S; Alves AD; Cavaco JS; Pontes JF; Guerreiro F; Rosa da Costa AM; Buttini F; Grenha A Int J Pharm; 2017 Aug; 529(1-2):433-441. PubMed ID: 28669623 [TBL] [Abstract][Full Text] [Related]
15. Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice. Verma RK; Kaur J; Kumar K; Yadav AB; Misra A Antimicrob Agents Chemother; 2008 Sep; 52(9):3195-201. PubMed ID: 18591268 [TBL] [Abstract][Full Text] [Related]
16. Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy. Gupta A; Sharma D; Meena J; Pandya S; Sachan M; Kumar S; Singh K; Mitra K; Sharma S; Panda AK; Gupta P; Gupta UD; Misra A Pharm Res; 2016 Aug; 33(8):1899-912. PubMed ID: 27095353 [TBL] [Abstract][Full Text] [Related]
17. Cytocompatibility and cellular interactions of chondroitin sulfate microparticles designed for inhaled tuberculosis treatment. Rodrigues S; Cunha L; Kollan J; Neumann PR; Rosa da Costa AM; Dailey LA; Grenha A Eur J Pharm Biopharm; 2021 Jun; 163():171-178. PubMed ID: 33838263 [TBL] [Abstract][Full Text] [Related]
18. Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis. Yadav AB; Muttil P; Singh AK; Verma RK; Mohan M; Agrawal AK; Verma AS; Sinha SK; Misra A Tuberculosis (Edinb); 2010 May; 90(3):188-96. PubMed ID: 20382085 [TBL] [Abstract][Full Text] [Related]
19. Partial biodistribution and pharmacokinetics of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to rhesus macaques. Kumar Verma R; Mukker JK; Singh RS; Kumar K; Verma PR; Misra A Mol Pharm; 2012 Apr; 9(4):1011-6. PubMed ID: 22397370 [TBL] [Abstract][Full Text] [Related]
20. Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month. Singh AK; Verma RK; Mukker JK; Yadav AB; Muttil P; Sharma R; Mohan M; Agrawal AK; Gupta A; Dwivedi AK; Gupta P; Gupta UD; Mani U; Chaudhari BP; Murthy RC; Sharma S; Bhadauria S; Singh S; Rath SK; Misra A Tuberculosis (Edinb); 2021 May; 128():102081. PubMed ID: 33915379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]